University of Bridgeport and TulsiHub Institute Partner to Launch First-of-Its-Kind Regenerative Medicine Program in Nation

Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for ...

NEEDHAM, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that the U.S. Food and Drug…

University of Bridgeport and TulsiHub Institute Partner to Launch First-of-its-Kind Regenerative Medicine Program in Nation

BRIDGEPORT, Conn., May 28, 2025 /PRNewswire/ -- University of Bridgeport (UB) is proud to announce a groundbreaking certificate program in the rapidly evolving field of Regenerative Medicine, offered in collaboration with the globally renowned TulsiHub Institute. This 12-week, CE-approved program…

FDA grants RMAT designation to AbelZeta’s CAR-T therapy

The US FDA has granted regenerative medicine advanced therapy (RMAT) designation to AbelZeta Pharma’s C-CAR168.